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Abstract
Background: Independent Component Analysis (ICA) is a method that models gene expression data as an action
of a set of statistically independent hidden factors. The output of ICA depends on a fundamental parameter: the
number of components (factors) to compute. The optimal choice of this parameter, related to determining the
effective data dimension, remains an open question in the application of blind source separation techniques to
transcriptomic data.
Results: Here we address the question of optimizing the number of statistically independent components in the
analysis of transcriptomic data for reproducibility of the components in multiple runs of ICA (within the same or
within varying effective dimensions) and in multiple independent datasets. To this end, we introduce ranking of
independent components based on their stability in multiple ICA computation runs and define a distinguished
number of components (Most Stable Transcriptome Dimension, MSTD) corresponding to the point of the qualitative
change of the stability profile. Based on a large body of data, we demonstrate that a sufficient number of dimensions
is required for biological interpretability of the ICA decomposition and that the most stable components with ranks
below MSTD have more chances to be reproduced in independent studies compared to the less stable ones. At the
same time, we show that a transcriptomics dataset can be reduced to a relatively high number of dimensions without
losing the interpretability of ICA, even though higher dimensions give rise to components driven by small gene sets.
Conclusions: We suggest a protocol of ICA application to transcriptomics data with a possibility of prioritizing
components with respect to their reproducibility that strengthens the biological interpretation. Computing too few
components (much less than MSTD) is not optimal for interpretability of the results. The components ranked within
MSTD range have more chances to be reproduced in independent studies.
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Background
Independent Component Analysis (ICA) is a matrix
factorization method for data dimension reduction [1].
ICA defines a new coordinate system in the multi-
dimensional space such that the distributions of the data
point projections on the new axes become as mutually
independent as possible. To achieve this, the standard
approach is maximizing the non-gaussianity of the data
point projection distributions [1]. ICA has been widely
applied for the analysis of transcriptomic data for blind
separation of biological, environmental and technical
factors affecting gene expression [2–6].
The interpretation of the results of any matrix
factorization-based method applied to transcriptomics
data is done by the analysis of the resulting pairs of
metagenes and metasamples, associated to each compo-
nent and represented by sets of weights for all genes and
all samples, respectively [6, 7]. Standard statistical tests
applied to these vectors can then relate a component to
a reference gene set (e.g., cell cycle genes), or to clinical
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annotations accompanying the transcriptomic study
(e.g., tumor grade). The application of ICA to multiple
expression datasets has been shown to uncover
insightful knowledge about cancer biology [3, 8]. In [3] a
large multi-cancer ICA-based metaanalysis of transcrip-
tomic data defined a set of metagenes associated with fac-
tors that are universal for many cancer types. Metagenes
associated with cell cycle, inflammation, mitochondria
function, GC-content, gender, basal-like cancer types
reflected the intrinsic cancer cell properties. ICA was also
able to unravel the organization of tumor microenviron-
ment such as the presence of lymphocytes B and T, myofi-
broblasts, adipose tissue, smooth muscle cells and
interferon signaling. This analysis shed light on the princi-
ples underlying bladder cancer molecular subtyping [3].
It has been demonstrated that ICA has advantages
over the classical Principal Component Analysis (PCA)
with respect to interpretability of the resulting compo-
nents. The ICA components might reflect both bio-
logical factors (such as proliferation or presence of
different cell types in the tumoral microenvironment) or
technical factors (such as batch effects or GC-content)
affecting gene expression [3, 5]. However, unlike princi-
pal components, the independent components are only
defined as local minima of a non-quadratic optimization
function. Therefore, computing ICA from different ini-
tial approximations can result in different problem solu-
tions. Moreover, in contrast to PCA, the components of
ICA cannot be naturally ordered.
To improve these aspects, several ideas have been
employed. For example, an icasso method has been de-
veloped to improve the stability of the independent com-
ponents by: (1) applying multiple runs of ICA with
different initializations; (2) clustering the resulting com-
ponents; (3) defining the final result as cluster centroids;
and (4) estimating the compactness of the clusters [9].
The resulting components can be then naturally ordered
from the most stable to the least stable ones. This rank-
ing is usually different from more commonly used inde-
pendent component rankings based on the value of the
used non-gaussianity measure (such as kurtosis) or the
variance explained by the components.
The fundamental question is the determination of the
number of independent components to produce. This
problem can be split into two parts: a) what dimension
should be selected for reducing the transcriptomic data
before applying ICA (determining the effective data di-
mension); and b) which is the most informative number
of components to use in the downstream analysis?
Determining the optimal effective data dimension for
application of signal deconvolution was a subject of re-
search in various fields. For example, ICA appeared to
be a powerful method for analyzing the fMRI (functional
magnetic resonance) data [9–12]. In this field, it was
shown that choosing a too small effective data dimen-
sion might generate “fused components,” not reflecting
the heterogeneity of the data, leading to a loss of inter-
esting sources (under-decomposition). At the same time,
choosing the effective dimension too high might lead to
signal-to-noise ratio deterioration, overfitting and split-
ting of the meaningful components (over-decompos-
ition) [10–12]. The influence of the effective dimension
choice on the ICA performance has not been well stud-
ied in the context of transcriptomic data analysis. For
example, in [3] each dataset was decomposed into a
number of components in an ad hoc manner (n = 20).
Several theoretical approaches for estimating effective
data dimension exist. The simplest ones, developed for
PCA analysis, are represented by the Kaiser rule aimed
at keeping a certain percentage of explained variance
and the broken stick model of resource distribution [13].
More sophisticated approaches employ the information
theory (e.g., Akaike’s information or Minimal Descrip-
tion Length criteria) [13] or investigate the local-to-
global data structure organization [14]. Also, computa-
tional approaches based on cross-validation have been
suggested in the literature [15]. Specifically for ICA ana-
lysis, few methods have been proposed to optimize the
effective dimension. For example, the Bayesian Informa-
tion Criterion (BIC) can be applied to the Bayesian for-
mulation of ICA for selecting the optimal number of
components [16].
Although many of the above theoretical methods are
“parameter-free,” selecting the best method for choosing
an effective dimension for transcriptomic data can be
challenging in the absence of a clearly defined validation
strategy. One possible approach to overcome this limita-
tion is to apply the same computational method to mul-
tiple transcriptomic datasets derived from the same tissue
and disease. In this situation, it is reasonable to expect
that a matrix factorization method should detect similar
signals in all datasets. By taking advantage of the rich col-
lection of public data such as The Cancer Genomic Atlas
(TCGA) [17] and Gene Expression Omnibus [18], it is
possible to compare and contrast the parameters of differ-
ent gene expression analysis methods such as ICA.
In this study, we used TCGA pan-cancer (32 different
cancer types) transcriptomic datasets and a set of six in-
dependent breast cancer transcriptomic datasets to
evaluate the effect of the number of computed inde-
pendent components on reproducibility and biological
interpretability of the obtained results. We evaluated the
reproducibility of ICA on three aspects: First, we ana-
lyzed the stability of the computed components with re-
spect to multiple runs of ICA; second, we analyse the
conservation of the computed components by varying
the choice of the reduced data dimension; and third, we
consider the reproducibility of the resulting set of ICA
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metagenes across multiple independent datasets. Our re-
producibility analysis thus explores 13,027 transcrip-
tomic profiles in 37 transcriptomic datasets, for which
more than 100,000 ICA decompositions have been
computed.
We finally defined a novel criterion adapted for choos-
ing the effective data dimension for ICA analysis of gene
expression, which takes into account the global proper-
ties of transcriptomic multivariate data. The Maximally
Stable Transcriptome Dimension (MSTD) is defined as
the maximal dimension where ICA does not yet produce
a large proportion of highly unstable signals. By numer-
ical experiments, we showed that components ranked by
stability within the MSTD range tend to be more repro-
ducible and easier to interpret than higher-order
components.
Results
Definition of component reproducibility measures used in
this study
Stability of an independent component, in terms of vary-
ing the initial starts of the ICA algorithm, is a measure
of internal compactness of a cluster of matched inde-
pendent components produced in multiple ICA runs for
the same dataset and with the same parameter set but
with random initialization. The exact index used for
quantifying the clustering is documented in the Methods
section. Conservation of an independent component in
terms of choosing various orders of ICA decomposition
is a correlation between matched components computed
in two ICA decompositions of different orders (reduced
data dimensions) for the same dataset. Reproducibility
of an independent component is an (average) correlation
between the components that can be matched after ap-
plying the ICA method using the same parameter set
but for different datasets. For example, if a component is
reproduced between the datasets of the same cancer
type, then it can be considered a reliable signal less af-
fected by technical dataset peculiarities. If the compo-
nent is reproduced in datasets from many cancer types,
then it can be assumed to represent a universal cancero-
genesis mechanism, such as cell cycle or infiltration by
immune cells. The details on computing correlations be-
tween components from different datasets are described
in Methods.
Maximally stable Transcriptome dimension (MSTD), a
novel criterion for choosing the optimal number of ICs in
transcriptomic data analysis
We used 37 transcriptomic datasets to analyze the sta-
bility and reproducibility of the ICA results conditional
on the chosen number of components. ICA has been ap-
plied separately to 37 cancer transcriptomic datasets
following the ICA application protocols as described in
Methods.
The proposed protocol depends on a fundamental par-
ameter M (effective dimension of the data and, at the
same time, the number of computed independent com-
ponents) whose effect on the stability of the ICs is inves-
tigated. For each transcriptomic dataset, the range of M
values 2–100 has been considered. For each value of M,
the data dimension is reduced to M by PCA and then
data whitening is applied. Subsequently, the actual signal
decomposition is applied in the whitened space by defin-
ing M new axes, each maximizing the non-gaussianity of
data point projections distribution.
For transcriptomic data, ICA decomposition provides:
(a) M metagenes ranked accordingly to their stability in
multiple runs (n = 100) of ICA; and (b) a profile of sta-
bility of the components (set of M numbers in [0,1]
range in descending order). Considering the largest data-
set METABRIC as an example, the behavior of the sta-
bility profile as a function of M is reported in Fig. 1a.
The results for stability analysis for other breast cancer
datasets are similar (See Additional file 1: Figure SF2).
To recapitulate the behaviour of many stability profiles,
the average stability of the first k top-ranked compo-
nents SM(k) is used (See Fig. 1b). For k = M, the average
stability of all computed components is denoted as SM
total.
Three major conclusions can be made from Fig. 1. First,
the average stability of the computed components SM
total
decreases with the increase of M, while the average sta-
bility of the first few top ranked components, e.g.,
SM(10), weakly depends on M (Fig. 1b). Moreover, SM
total
is characterized by the presence of local maxima, defin-
ing certain distinguished values of M that correspond to
the (locally) maximally stable set of components
(Fig. 1b). Third, the stability profiles for various
values of M can be classified into those for which
the stability values are distributed approximately
uniformly and those (usually, in higher dimensions)
forming a large proportion of the components with
low stability (Iq between 0.2 and 0.4) (Fig. 1a).
Considering these observations, we hypothesized that
the optimal number of independent components – large
enough to avoid fusing meaningful components and yet
small enough to avoid producing an excessive amount of
highly unstable components – should correspond to the
inflection point in the distribution of the stability pro-
files (Fig. 1a). To find this point, the stability measures
have been clustered along two lines, which is analogous
of 2-means clustering but with lines as centroids. In this
clustering, the line with a steeper slope (Fig. 1a, blue
line) grouped the stability profiles with uniform distribu-
tion, while another line (Fig. 1a, red line) matched the
mode of low stability components. The intersection of
these lines provided a consistent estimate of the effective
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number of independent components. We call this esti-
mate Maximally Stable Transcriptome Dimension
(MSTD) and in the following we investigated its proper-
ties. We note that, as in various information theory-
based criteria (BIC, AIC), this estimate is free of parame-
ters (thresholds), and it only exploits the property of the
qualitative change in the character of the stability profile
in higher data dimensions for transcriptomic data.
In most of the cancer transriptomics datasets used in
our analysis, MSTD was found to correspond roughly to
the average stability profile SM
total ≈ 0.6 (Additional file 1:
Figure SF2). In Fig. 1d, the dependence of MSTD on the
number of samples contained in the transcriptomic data-
set is investigated for all the 37 transcriptomic datasets.
As shown in Additional file 2: Figure SF1, MSTD in-
creased with the number of samples; however, this trend
was weaker than other estimates of an effective dimen-
sion such as Kaiser rule and broken stick distribution-
based data dimension estimates. Finally, the fraction of
variance explained by the linear subspace spanned by
MSTD number of components was evaluated (Fig. 1e),
and it was observed that the fraction of variance ex-
plained varied from 0.45 to 0.75 with a median of 0.56.
Underestimating the effective dimension (M < MSTD)
leads to a poor detection of known biological signals
Previous large-scale ICA-based meta-analyses [3] have
shown that some of the ICs derived from the decompos-
ition of a cancer transcriptomic data were clearly and
uniquely associated with known biological signals. For
example, one of these signals was the one connected to
proliferative status of tumors. Another example was
given by the signals related to the infiltration of immune
cells that were also strongly heterogeneous across cancer
patients.
We have checked the reproducibility of several meta-
genes obtained in previous meta-analyses [3] for all ICA
decompositions as a function of M. For this analysis, we
employed the METABRIC breast cancer dataset, which
was not included in the input data of the previous publi-
cation [3] and thus it had not been used to derive the
metagenes of that work. In addition, we checked how
a b
d e
c
Fig. 1 Defining Maximally Stable Transcriptomic Dimension (MSTD) value in 37 transcriptomics cancer datasets (13,027 samples in total). In a-c)
an example of the analysis is presented for the largest breast cancer dataset METABRIC. a stability profiles for ICA decompositions in various
dimensions (from 2 to 100) shown by grey lines. Two-line clustering result is shown by blue and red dashed lines, with MSTD determined as the
point of their intersection (vertical dashed line). b average stability profile SM
total (blue line) and the average stability of 10 most stable components SM(10)
(red line). c visualizing the results of computing ICA 100 times with MSTD = 29 components in the METABRIC dataset and component clustering
(icasso package, Canonical Correlation Analysis (CCA) plot). Each black point represents a component, red lines show significant correlations between
them, polygons show the convex hull area of the clusters. d Dependence of MSTD on the number of samples for all datasets. e Dependence of the
fraction of explained variance on MSTD for all datasets
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the significance of intersections between the genes defin-
ing the components and several reference gene sets
(produced independently of the ICA analyses) behaved
as a function of M.
We applied the previously developed correlation-based
approach to match previously identified metagenes with
the ones computed for a new METABRIC dataset (see
Methods section). The components were oriented
accordingly to the direction of the heaviest tail of the pro-
jection distribution. When matching an oriented compo-
nent to the previously defined set of metagenes, we
verified that the resulting maximal correlation should be
positive, i.e. large positive weights in one metagene should
correspond to large positive weights in another metagene.
One of the most important case studies is reproduci-
bility of the “proliferative” metagene in different data
dimensions. It is investigated in Fig. 2a-c. For this meta-
gene, we computed correlations with M newly identified
independent components. As an example, the profile of
correlations for M = 100 is shown in Fig. 2b. It can be
seen that one of the components (ranked #7 by stability
analysis) is much better correlated to the proliferative
metagene than any other component. Therefore, compo-
nent #7 is called “best matched” in this case, for
M = 100, and “well separable.” Repeating this analysis
for all M and reporting the observed maximal correl-
ation coefficient and the corresponding stability value
gives a plot shown in Fig. 2a. Separability of the best
matched component from the other components is visu-
alized in Fig. 2c.
As it can be seen from Fig. 1a, the biologically ex-
pected signals (i.e., cell cycle) can be poorly detected for
M < MSTD; however, once the best matching compo-
nent with significant correlation was found, it remained
unique and was detected robustly even for very large
values of M> > MSTD. For example, even when 100
components (M) were computed, the correlation be-
tween the previously defined proliferative metagene and
the best matched independent component did not di-
minish (Fig. 2a). Moreover, the separability of the best
matched component from the rest of the components
was not ruined (Fig. 2c). In this example, the identifica-
tion of cell cycle component remained clear (large and
well-separated correlation coefficient) for M> > MSTD.
This result was consistent and complementary when com-
pared with the previously observed weak dependence of
SM(10) on M. Indeed, the “proliferative” best matched
component had stability rank k in the range [6, 11]. That
is, it remained stable in ICA decompositions in all dimen-
sions. Moreover, the intersection of a recently established
proliferation gene signature [19] with the set of top con-
tributing genes of the best matched component improved
with increasing M and saturated (Fig. 2d). This proves that
the detection of the proliferation-associated signal with
ICA does not depend on the ICA-based definition of the
proliferative metagene.
Together with the proliferative signal, other metagenes
from the previously cited ICA-based meta-analysis [3] were
robustly identified in our analysis. In Fig. 2e-h, we showed
the correlation with the best matching component for the
metagenes associated with the presence of myofibroblasts,
inflammation, interferon signaling and immune system, as
a function of M. These plots illustrated different scenarios
that can result from such analysis. The myofibroblast-
associated metagene was robustly detected for all values of
M > 7 (Fig. 2f). However, the stability of the best matching
component was deteriorated in higher-order ICA decom-
positions (M > 45). For the inflammation-associated meta-
gene, an ICA decomposition with M > 38 was needed to
robustly detect a component that correlates with the meta-
gene (Fig. 2e).
Interestingly, the immune-associated metagene was
found robustly matched starting from M = 4. How-
ever, in higher-order decompositions (starting from
M = 30) it could be matched to several components
that can be associated with specific immune system-
related signals (Fig. 2h-i). Hypergeometric tests ap-
plied to the sets of top-contributing genes (weights
larger than 5.0) allowed us to reliably interpret these
components as being associated with the presence of
three types of immune-related cells: T cells (corrected en-
richment p-value = 10−39 with “alpha beta T cells” signature
[20], other immune signatures are much less significant), B
cells (p-value = 10−7 with “B cells, preB.FrD.BM” signature)
and myeloid cells (p-value = 10−78 with “Myeloid Cells,
DC.11cloSer.Salm3.SI” signature).
Overestimating the number of components (M> > MSTD)
produces multiple ICs driven by small gene sets
We observed that the higher-order ICA decompositions
(M> > MSTD) produced a larger number of components
driven by small gene sets (frequently, one gene), such
that the projections of the genes in this “outlier” set is
separated by a relatively large gap with the rest of the
projections. We thus designed a simple algorithm to dis-
tinguish such components driven by a small gene set
from all the others. The names of the genes composing
these small sets were used for annotating the corre-
sponding components (Fig. 3a, right part).
It was observed that the presence of such “small gene
set-driven” components is a characteristic of higher-
order ICA decompositions (M> > MSTD), much less
present in ICA decompositions with M ≤ MSTD (com-
pare Fig. 3a and Additional file 1: Figure SF2).
To check the biological significance of the outlier
genes, we considered as a case study the higher-order
(M = 100) ICA decomposition of the METABRIC breast
cancer dataset. We collected all those genes found to be
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drivers of at least one “small gene set-driven” compo-
nent. We obtained in this way a set of 98 genes listed
in Additional file 3: Table ST2. This list appeared to
be strongly enriched (p-value = 10−12 after correction
for multiple testing) in the genes of the signature
DOANE_BREAST_CANCER_ESR1_UP “Genes up-
regulated in breast cancer samples positive for ESR1
compared to the ESR1 negative tumors” from Molecular
Signature Database [21] and several other specific to
breast cancer gene signatures. This analysis thus
a b c
d e f
g h i
Fig. 2 Analysis of reproducibility of previously identified metagenes in independent components of the METABRIC dataset. a,e,f,g,h show
correlations (see Methods section) with the cell cycle, inflammation, myofibroblast, interferon signaling, immune-related metagenes from [3] as a
function of the chosen data dimension M, and the stability of the best matched component. c shows the ratio between the correlation value of
the proliferation metagene with the best matched component and the second best correlation (gap). d shows an intersection (Jaccard index) of
the Freeman’s cell cycle signature [19] and the set of top-contributing genes (projection > 5.0) from the proliferation-associated independent
component. b,i correlation of the cell cycle and immune-related metagene with the best matched component in the M = 100 ICA decomposition
as a function of the stability-based component rank. In all plots, the vertical dashed line shows the MSTD value for the METABRIC dataset
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Fig. 3 Analysis of component reproducibility in independent datasets. a Graph of reciprocal correlations showing the reproducibility of the
metagenes of independent components in 6 independent breast cancer datasets. Each node here is an independent component, represented by
a metagene, from an ICA decomposition with M = 100 components. Edges show only reciprocal correlations between metagenes with Pearson
correlation >0.3. Triangles (on the right) show the components driven by the expression of a small group of genes (frequently, one gene). Node
size reflects the rank of the component based on the stability in multiple runs of fastICA (larger nodes are more stable ones). The edge width and the
color reflect the value of the correlation coefficient between two metagenes, with thicker edges showing larger correlation values. Several pseudo-cliques
of highly reproducible components are annotated either by the dominating small group of genes (pseudo-cliques of triangle nodes), or by comparing to
the results of the previously published large-scale ICA-based analysis of gene expression [3] or by performing the hypergeometric test
using the set of top-contributing genes (with projection larger than 5.0 onto the component). The analogous correlation graph computed
for MSTD number of components is provided in Additional file 7: Figure SF3. b average reproducibility score (sum of reciprocal correlation
coefficients for an independent component) for the correlation graph shown in a), as a function of the relative (component rank minus MSTD value
for a given dataset, for stability-based ranking) or absolute (for other ranking types) component rank. It is clear that only stability-based ranking matches
the reproducibility score
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suggested that at least some of the identified “small
gene set-driven” components are not the artifacts of
the ICA decomposition, but they can be biologically
meaningful and reproducible in independent datasets
(Fig. 3a, right part).
Most stable components with stability rank ≤ MSTD have
more chances to be reproduced across independent
datasets for the same cancer type
It would be reasonable to expect that the main biological
signals characteristic for a given cancer type should be
the same when one studies molecular profiles of differ-
ent independent cohorts of patients. Therefore, we ex-
pect that for multiple datasets related to the same
cancer type, ICA decompositions should be somewhat
similar; hence, reciprocally matching each other. We
called this expected behavior “reproducibility,” and here
we studied this by applying ICA to six relatively large
breast cancer transcriptomic datasets. Of note, these
datasets were produced using various technologies of
transcriptomic profiling (Additional file 4: Table ST1).
To identify the reproducible components, we applied
the same methodology as in the previously published
ICA-based gene expression meta-analysis [3]. We
decomposed the six datasets separately and then con-
structed a graph of reciprocal correlations between the
obtained metagenes. Correlation between two sets of
components is called reciprocal when a component from
one set is the best match (maximally correlated) to a
component from another set, and vice versa (see
Methods for a strict definition).
Pseudo-cliques in this graph, consisting of several
nodes, correspond to reproducible signals detected by
ICA. As shown in Fig. 3, multiple reproducible signals
were identified in the analysis. Some of them correspond
to signals already identified in [3] (e.g., cell cycle, inter-
feron signaling, microenvironment-related signals), and
some correspond to newly discovered biological signals
(e.g., ERBB2 amplicon-associated). Some other pseudo-
cliques are associated with “small gene set-driven” com-
ponents (frequently, one gene-driven), such as TFF1–3-
associated or SCGB2A1–2-associated components.
The genes driver of reproducible and “small gene set-
driven” components (S100P, TFF1, TFF3, SCGB2A1,
SCGB1D2, SCGB2A2, LTF, CEACAM6, CEACAM5 be-
ing most remarkable examples) have been investigated
in detail, to further check their biological interest. They
were found to be the genes known to be associated with
breast cancer progression [22]. For example, seven of
the nine previously mentioned genes form a part of a
gene set known to be up-regulated in the bone relapses
of breast cancer (M3238 gene set from MSigDB).
To quantify the reproducibility of the components, we
computed a reproducibility score. It is a sum of
correlation coefficients between the component and all
reciprocally correlated components from other datasets.
By construction, the maximum value of the score is 5,
which meant that a component with such a score would
be perfectly correlated with the reciprocally related com-
ponents from five other datasets. We studied the de-
pendence of this score as a function of the relative to
MSTD component stability-based rank (Fig. 3b). From
this study, it follows that even for the high-order ICA
decompositions, the components ranked by their stabil-
ity within MSTD range, have an increased likelihood of
being reproduced in independent datasets collected for
the same cancer type.
To show that the stability-based ranking of genes is
more informative compared with the standard rankings of
independent components, we performed a computational
analysis in which we compared the stability-based ranking
with the rankings based on non-gaussianity (kurtosis) and
explained variance. These two measures are frequently
used to rank the independent components [6]. From Fig.
3b it is clear that the stability-based ranking of independ-
ent components corresponds well to the reproducibility
score, while two other simpler measures do not.
It can also be shown that the total number of recipro-
cal correlations with relatively large correlation coeffi-
cients (|r| > 0.3) between ICA-based metagenes
computed for several independent datasets is signifi-
cantly bigger when the component stabilization ap-
proach is applied (Additional file 5: Figure SF4). This
proves the utility of the applied stabilization-based
protocol of ICA application to transcriptomic data.
Computing large number of components (M> > MSTD)
does not strongly affect the most stable ones
We lastly used ICA decompositions of 37 transcriptomic
datasets to compare the ICA decompositions corre-
sponding to M = MSTD with the higher-order decom-
positions, M = 50 or M = 100.
It was found that the components calculated in lower
data dimensions can be relatively well matched to the
components from higher-order ICA decompositions
(Fig. 4). More precisely, 90% of the components defined
for M = MSTD had a reciprocal best matched compo-
nent in the M = 100 ICA decomposition. Most stable
components had a clear tendency to be reproduced with
high correlation coefficient (r > 0.8). Only 10% of the
components had only non-reciprocal or too small corre-
lations between two decompositions (in other words, not
conserved in higher-order ICA decompositions).
Approximately 15% of the components in M = MSTD
ICA decomposition together with reciprocal maximal cor-
relation also had a non-reciprocal correlation to one of
the components in M = 100 ICA decomposition (Fig. 4).
This case can be described as splitting a component into
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two or more components in the higher-order ICA decom-
positions. At least one such split had a clear biological
meaning, namely the splitting of the component repre-
senting the generic “immune infiltrate.” The resulting
“split” components more specifically represented the role
of T cells, B cells and myeloid cells in the tumoral micro-
environment (see the “Underestimating the effective di-
mension…” Results section).
Discussion
Our results shed light on the organization of the
multivariate distribution of gene expression in the
high-dimensional space. It appears that the organization
contained two relatively well separated parts: the dense
one of a relatively small effective dimension and the sparse
one. The former contained the genes from within co-
regulated modules that contained from few tens to few
hundreds of genes. The latter was spanned by the genes
with unique regulatory programs (perhaps tissue-specific)
weakly shared by the other genes. Here the sparsity was
understood in the sense of low local multivariate distribu-
tion density.
Independent Component Analysis can capture both
these parts of the multivariate distribution. However,
while the dense part defined independent components
with approximately uniformly distributed stabilities,
starting from highly stable to less stable, the sparse part
was spanned by the components characterized mostly by
small stability values.
This organization of the gene expression space is cap-
tured in the distribution of ICA stability profiles for
varying M, which allowed us to define the Maximally
Stable Transcriptome Dimension (MSTD) value, roughly
reflecting the dimension of the dense part of the gene
expression distribution. In one hand, when underdecom-
posing (compressing too much by dimension reduction,
M < MSTD) a transcriptomic dataset, the resulting inde-
pendent components are hard to interpret. In the other
hand, overdecomposing transcriptomes (choosing the
effective dimension much bigger than MSTD) is not
dramatically detrimental: one can choose to explore a
relatively multi-dimensional subspace of a transcrip-
tomic dataset, taking into account that applying matrix
factorization methods in higher dimensions becomes
computationally challenging and prone to bad algorithm
convergence. Nevertheless, higher-order decompositions
might allow capturing the behavior of some tissue-
specific or cancer type-specific biomarker genes from
the sparse part of the distribution, which can be found
reproducible in other independent studies.
In our computational experiments, we selected 100 as
the maximum order of ICA decomposition (M) to test.
However it is possible to examine even higher orders of
ICA decompositions, reducing the data to more than
100 dimensions, but not more than the total number of
samples, of course. In practice, computing ICA in such
high dimension leads to significant deterioration of the
fastICA algorithm convergence, so exploring M > 100
Fig. 4 Conservation or non-conservation of independent components in higher than MSTD dimensions. ICA decomposition in MSTD data dimension
is compared with the one of dimension 50 and 100. Table on the left: list of different scenario with the relative frequency of each of them estimated
for a pan-cancer TCGA dataset. Plots on the right show the frequency of finding the reciprocally correlated component in the higher dimension and
the average correlation coefficient of the reciprocal correlation, as a function of the relative rank of the component (component rank minus MSTD
value for a given dataset)
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might be too expensive in terms of computational time.
Moreover, our study suggests that the most interesting
for interpretation components are usually positioned
within the first few ten top ranks: therefore, 100 seems
to be a reasonable limit for dimension reduction when
applying ICA to transcriptomic data.
Our proposed approach can be used for comparing in-
trinsic reproducibility, at different levels, of various
matrix factorization methods. For example, it would be
of interest to compare the widely used Non-negative
matrix factorization (NMF) method [6, 7] with ICA to
assess reproducibility of extracted metagenes in inde-
pendent datasets of the same nature.
More generally, systematic reproducibility analysis can
be a useful approach for establishing the best practices
of application of the bioinformatics methods.
Conclusion
By using a large body of data and comparing 0.1 million
decompositions of transcriptomic datasets into the sets
of independent components, we have checked systemat-
ically the resulting metagenes for their reproducibility in
several runs of ICA computation (measuring stability),
for their reproducibility between a lower order and
higher-order ICA decompositions (conservation), and
between metagene sets computed for several independ-
ent datasets, profiling tumoral samples of the same can-
cer type (reproducibility).
From the first of such analyses, we formulated a minim-
ally advised number of dimensions to which a transcrip-
tomic dataset should be reduced called Maximally Stable
Transcriptome Dimension (MSTD). Reducing a transcrip-
tomic dataset to a dimension below MSTD is not optimal
in terms of the interpretability of the resulting ICA com-
ponents. We showed that for relatively large transcrip-
tomic datasets, MSTD could vary from 15 to 30 and that
the number of samples matters relatively weakly.
From the second analysis, we concluded that the sug-
gested protocol of ICA application to transcriptomic
data is conservative, i.e., the components identified in a
higher dimension (for example, in one hundred dimen-
sional space) can be robustly matched with those com-
ponents obtained in the dimensions comparable with
MSTD. Moreover, we described an effect of interpretable
component splitting in higher dimensions, leading to
detection of finer-grained signals (e.g., related to the de-
composition of the immune infiltrate in the tumor
microenvironment). At the same time, the application of
ICA in high dimensions resulted in a greater proportion
of unstable components, many of them were driven by
expression of small (one to three members) gene sets.
Yet, some of these small gene set-driven components
were highly reproducible and biologically meaningful.
From the third analysis, we established that the used
protocol of ICA application, with ranking the independent
components based on their stability, prioritized those com-
ponents having more chances to be reproduced in inde-
pendent transcriptomic datasets. Moreover, when ICA was
applied in higher dimensions, the components within the
MSTD range still have more chances to be reproduced.
In sum, our results confirmed advantageous features
of ICA applied to gene expression data from different
platforms, leading to interpretable and quantifiably re-
producible results. Comparing ICA analyses performed
in various dimensions and multiple independent datasets
for the same cancer types allow prioritizing of the most
reliable and reproducible components which can be
quantitatively recapitulated in the form of metagenes or
the sets of top contributing genes. We expect that ICA
will demonstrate similar properties in other large-scale
transcriptomic data collections such as scRNA-seq data.
Methods
Transcriptomics cancer data used in the analysis
Expression data derived for 32 solid cancer types (ACC,
BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA,
GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD,
LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC,
SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS,
UVM) were downloaded from the TCGA web-site and
internally normalized. Normalized breast cancer datasets
from CIT, BCR, WANG, BEKHOUCHE were re-used
from the previous study [3]. Normalized METABRIC
breast cancer expression dataset was downloaded from
cBioPortal at this link http://www.cbioportal.org/study?
id=brca_metabric. When it was not already the case, the
data values were converted into logarithmic scale.
The list of breast cancer transcriptomic datasets used
for reproducibility study is available in Additional file 4:
Table ST1.
ICA decompositions computation
We applied the same protocol of application of ICA de-
composition as in [3]. In the ICA decomposition X ≈ AS,
X is the gene expression (sample vs gene) matrix, A is the
(sample vs. component) matrix describing the loadings of
the independent components, and S is the (component vs.
gene matrix) describing the weights (projections) of the
genes in the components. To compute ICA, we used the
fastICA algorithm [1] accompanied by the icasso package
[23] to improve the components estimation and to rank
the components based on their stability. ICA was applied
to each transcriptomic dataset separately.
For each analysed transcriptomic dataset, we computed
M independent components (ICs), using pow3 nonlinearity
and symmetrical approach to the decomposition, where
M = [2…50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100]. In those
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cases, when M exceeded the total number of samples,
the maximum M was chosen equal to 0.9 multiplied by
the number of samples (moderate dimension reduction
improves convergence). We found that the MATLAB
implementations of fastICA performs superior to other
implementations (such as those provided in R [24]).
The computational time required for performing all the
0.1 million ICA decompositions used in this study is
estimated in ~1500 single processor hours using
MATLAB while other implementations would not
make this analysis feasible at all. In our analysis, we
used Docker with packaged compiled MATLAB code
for fastICA together with MATLAB Runtime environ-
ment, which can be readily used in other applications
and does not require MATLAB installed [25]. An ex-
ample of computational time needed for the analysis of
two transcriptomic datasets of typical size (full tran-
scriptome, from 200 to 1000 samples) is provided in
Additional file 6: Figure SF5. As a rough estimate, it
takes 3 h to analyze a transcriptomic dataset with 200
samples and 7 h to analyze a dataset with 1000 samples,
using an ordinary laptop. In each such analysis, more
than 2000 ICA decompositions of different orders have
been made.
The algorithm for determining the most stable
Transcriptome dimension (MSTD)
1) Define two numbers [Mmin, Mmax] as the minimal
and maximal possible numbers of the computed
components.
2) Define the number K of ICA runs for estimating the
components stability. In all our examples, we used
K = 100.
3) For each M between Mmin and Mmax (or, with some
step) do
3.1) Compute K times the decomposition of the
studied dataset into M independent components
using the fastICA algorithm. This results in
computation of MxK components.
3.2) Cluster MxK components into M clusters using
agglomerative hierarchical clustering algorithm with
the measure of dissimilarity equal to 1-|rij|, where rij
is the Pearson correlation coefficient computed
between components.
3.3) For each cluster Ck out of M clusters (C1, C2,…,
CN) compute the stability index using the following
formula
Iq Ckð Þ ¼ 1
Ckj j2
X
i;j∈Ck
∣rij∣−
1
∣Ck∣
P
l≠k
∣Cl∣
X
i∈Ck
X
j∉Ck
∣rij∣
where |Ck| denotes the size of the kth cluster.
3.4) Compute the average stability index for M clusters:
S Mð Þ ¼ 1
M
X
k
Iq Ckð Þ
4) Select the MSTD as the point of intersection of the
two lines approximating the distribution of stability
profiles (Fig. 1a). The lines are computed using a
simple k-lines clustering algorithm [26] for k = 2,
implemented by the authors in MATLAB, with the
initial approximations of the lines matching the
abscissa and the ordinate axes of the plot.
The index used in 3.3 is a widely used index of
clustering quality defined as a difference between the
average intra-cluster similarity and the average
inter-cluster similarity. In [9] this index was
introduced to estimate the quality of clustering of
independent components after multiple runs with
random initial conditions, and tested in application
to fMRI data. In the case of clustering independent
components, Iq = 1 corresponds to the case of
perfect clustering of components such that all the
components in one cluster are correlated with each
other with |r| = 1, and that all components in the
same cluster are orthogonal to any other component
(in the reduced and whitened space).
Comparing metagenes computed for different datasets
and in different analyses
Following the methodology developed previously in [3],
the metagenes computed in two independent datasets
were compared by computing a Pearson correlation co-
efficient between their corresponding gene weights.
Since each dataset can contain a different set of genes,
the correlation is computed on the genes which are
common for a pair of datasets. Note that this common
set of genes can be different for different pairs of data-
sets. The same correlation-based comparison was done
with previously defined and annotated metagenes. We
computed the correlation only between those genes hav-
ing projection value more than 3 standard deviations in
the identified component.
When comparing two sets of metagenes A = {A1,…,AM}
and B = {B1,….,BN}, in order to do component matching,
we focused on the maximal correlation of a metagene
from one set with all components from another set. If
Bi = arg max(corr(Aj,B)) then Bi is called best matched, for
Aj, metagene from the set B. If Bi = arg max(corr(Aj,B))
and Aj = arg max(corr(Bi,A)), then the correlation between
Bi and Aj is called reciprocal.
In all correlation-based comparisons, the absolute
value of the correlation coefficient was used.
The orientation of independent components was
chosen such that the longest tail of the data projection
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distribution would be on the positive side. Then, for
quantifying an intersection between a metagene and a
reference set of genes (e.g., cell cycle genes), simple
Jaccard index was computed between the reference
gene set and the set of top-contributing genes to the
component, with positive weights >5.0.
Determining if a small gene set is driving an independent
component
To distinguish whether an independent component is
driven by a small gene set, the distribution of gene
weights Wi from the component was analyzed. For each
tail of the distribution (positive and negative), the tail
weight was determined as the total absolute sum of
weights of the genes exceeding certain threshold Wtop.
The heaviest tail of the distribution was identified as the
tail with the maximum weight. For the heaviest tail and
for the set of genes P with absolute weights exceeding
Wtop, sorted in descending order by absolute value, we
studied the gap distribution of values Gi = Wi/Wi+1, i∈
P. If there was a single value of Gi exceeding a threshold
Gmax, then the component was classified as being driven
by a small set of genes corresponding to the indices {i;
i ≤ max(k; Gk ≤ G
max)}. The values Wtop = 3.0, Gmax = 1.5
collected the maximal gene set size = 3 in all ICA de-
compositions. These are few genes with atypically high
weights separated by a significant gap from the rest of
the distribution (note that these genes cannot always be
considered outliers since they and the resulting inde-
pendent components can be reproducible in independ-
ent datasets).
Additional files
Additional file 1: Figure SF2. Estimating MSTD dimension for six breast
cancer datasets. The notations are the same as in Fig. 1. (PDF 479 kb)
Additional file 2: Figure SF1. Standard estimations of intrinsic
dimensionality (by Keiser rule or by broken stick distribution) of cancer
datasets. (PDF 288 kb)
Additional file 3: Table ST2. Genes associated with ICA components
of the METABRIC dataset, in the case when a component is driven by a
small group of genes (frequently, one gene). Gene names marked in bold
also drive independent components in several other breast cancer datasets
and the corresponding components are reciprocally reproducible in terms
of the correlation of the whole ICA-based metagenes. (XLSX 10 kb)
Additional file 4: Table ST1. Breast cancer transcriptomic datasets used
for the analysis of component reproducibility in independent datasets.
(XLSX 13 kb)
Additional file 5: Figure SF4. The histograms of the total number of
reciprocal correlations in the correlation graph such as the one shown in
Fig. 3, with and without applying the component stabilization approach.
(PDF 164 kb)
Additional file 6: Figure SF5. Computational time for ICA decomposition
of different orders from 2 to 100 with step 5, using compiled MATLAB fastICA
implementation and stability analysis by re-computing fastICA from 100
various initial conditions. The computation is made using an ordinary laptop
with Intel Core i7 processor and 16Gb of memory, in a single thread. The
BRCA BEK dataset (from [27]) contains 10,000 genes in 197 samples, and the
BRCA TCGA dataset (from [28]) contains 20,503 genes in 1095 samples. The
overall timing for computing all ICA decomposition with their stability
analysis is 3.0 h for BRCA BEK dataset, and 6.5 h for BRCA TCGA dataset.
These computations can be repeated using BIODICA software [29]
(https://github.com/LabBandSB/BIODICA), by launching ICA computation in
scanning mode. (PDF 361 kb)
Additional file 7: Figure SF3. Graph of reciprocal correlations between
components computed with MSTD choice for the reduced dimension
and the number of components. The size of the points reflects their
stability (larger points corresponds to more stable components). The
color and the width of the edges reflect the Pearson correlation
coefficient. Propositions of annotations of the pseudo-cliques in the
graph are made based on the comparison with previously annotated
metagenes [3] and the analysis of the top contributing genes using
hypergeometric test and the toppgene web tool [30]. (PDF 315 kb)
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